Search Results
Adam Brufsky, MD, PhD, considers the investigation of poziotinib in HER2+ metastatic breast cancer
Adam Brufsky, MD, PhD, describes the treatment landscape of HER2+ metastatic breast cancer
Adam Brufsky, MD, PhD: Considerations for Different Therapies in Breast Cancer
Dr. Domchek Discusses Immunotherapy in Breast Cancer
How I found out I had Breast cancer at 46
Size, structure help poziotinib pose threat to deadly exon 20 lung cancer